Those multiple anticancer drugs not effective for CYLD-negative cancer cells, are categorized as the cytotoxic chemotherapeutic agents, suggesting that loss of CYLD expression may also affect cell cycle progression or apoptosis [49]. The gene discussed is CYLD; the disease is cancer.